Status: current, Defined. Date: 30-Nov 2015. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3849641000168112 | Soflax (Ascent Pharma) (docusate sodium 50 mg + senna leaf powder 5 mg + sennoside B 8 mg) tablet, 100 tablets, bottle (containered trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3849651000168114 | Soflax (Ascent Pharma) tablet, 100, bottle | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Soflax (Ascent Pharma) tablet, 100, bottle | Is a | containered trade product pack | true | Inferred relationship | Some | ||
| Soflax (Ascent Pharma) tablet, 100, bottle | Is a | Soflax (Ascent Pharma) tablet, 100 | true | Inferred relationship | Some | ||
| Soflax (Ascent Pharma) tablet, 100, bottle | has TPUU | Soflax (Ascent Pharma) tablet | true | Inferred relationship | Some | 1 | |
| Soflax (Ascent Pharma) tablet, 100, bottle | has container type | bottle | true | Inferred relationship | Some | ||
| Soflax (Ascent Pharma) tablet, 100, bottle | has TP | Soflax (Ascent Pharma) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Reference Sets
Australian Register of Therapeutic Goods identifier reference set (foundation metadata concept)
Containered trade product pack reference set
FHIR